Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Tetracycline and fluoroquinolone resistance in clinical Ureaplasma spp. and Mycoplasma hominis isolates in France between 2010 and 2015.

Meygret A, Le Roy C, Renaudin H, Bébéar C, Pereyre S.

J Antimicrob Chemother. 2018 Oct 1;73(10):2696-2703. doi: 10.1093/jac/dky238.

PMID:
29986031
2.

Interaction of Mycoplasma hominis PG21 with Human Dendritic Cells: Interleukin-23-Inducing Mycoplasmal Lipoproteins and Inflammasome Activation of the Cell.

Goret J, Béven L, Faustin B, Contin-Bordes C, Le Roy C, Claverol S, Renaudin H, Bébéar C, Pereyre S.

J Bacteriol. 2017 Jul 11;199(15). pii: e00213-17. doi: 10.1128/JB.00213-17. Print 2017 Aug 1.

3.

Cloning, Stability, and Modification of Mycoplasma hominis Genome in Yeast.

Rideau F, Le Roy C, Descamps ECT, Renaudin H, Lartigue C, Bébéar C.

ACS Synth Biol. 2017 May 19;6(5):891-901. doi: 10.1021/acssynbio.6b00379. Epub 2017 Feb 7.

PMID:
28118540
4.

Surface lipoproteome of Mycoplasma hominis PG21 and differential expression after contact with human dendritic cells.

Goret J, Le Roy C, Touati A, Mesureur J, Renaudin H, Claverol S, Bébéar C, Béven L, Pereyre S.

Future Microbiol. 2016;11(2):179-94. doi: 10.2217/fmb.15.130. Epub 2016 Feb 5.

PMID:
26849083
5.

Molecular Epidemiology of Mycoplasma pneumoniae: Genotyping Using Single Nucleotide Polymorphisms and SNaPshot Technology.

Touati A, Blouin Y, Sirand-Pugnet P, Renaudin H, Oishi T, Vergnaud G, Bébéar C, Pereyre S.

J Clin Microbiol. 2015 Oct;53(10):3182-94. doi: 10.1128/JCM.01156-15. Epub 2015 Jul 22.

6.

Comparison of Mycoplasma pneumoniae Infections in asthmatic children versus asthmatic adults.

Bébéar C, Raherison C, Nacka F, de Barbeyrac B, Pereyre S, Renaudin H, Girodet PO, Marquant F, Desjardins S, Chêne G, Fayon M.

Pediatr Infect Dis J. 2014 Mar;33(3):e71-5. doi: 10.1097/INF.0000000000000063.

PMID:
24030350
7.

Identification and subtyping of clinically relevant human and ruminant mycoplasmas by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Pereyre S, Tardy F, Renaudin H, Cauvin E, Del Prá Netto Machado L, Tricot A, Benoit F, Treilles M, Bébéar C.

J Clin Microbiol. 2013 Oct;51(10):3314-23. doi: 10.1128/JCM.01573-13. Epub 2013 Jul 31.

8.

Diversity of Mycoplasma hominis clinical isolates from Bordeaux, France, as assessed by multiple-locus variable-number tandem repeat analysis.

Férandon C, Peuchant O, Renaudin H, Bébéar C.

BMC Microbiol. 2013 May 28;13:120. doi: 10.1186/1471-2180-13-120.

9.

Clonal spread of Mycoplasma pneumoniae in primary school, Bordeaux, France.

Pereyre S, Renaudin H, Charron A, Bébéar C.

Emerg Infect Dis. 2012 Feb;18(2):343-5. doi: 10.3201/eid1802.111379. No abstract available.

10.

Method comparison for molecular typing of French and Tunisian Mycoplasma genitalium-positive specimens.

Cazanave C, Charron A, Renaudin H, Bébéar C.

J Med Microbiol. 2012 Apr;61(Pt 4):500-6. doi: 10.1099/jmm.0.037721-0. Epub 2011 Dec 8.

PMID:
22160316
11.

Potential role of Mycoplasma hominis in interleukin (IL)-17-producing CD4+ T-cell generation via induction of IL-23 secretion by human dendritic cells.

Truchetet ME, Beven L, Renaudin H, Douchet I, Férandon C, Charron A, Blanco P, Schaeverbeke T, Contin-Bordes C, Bébéar C.

J Infect Dis. 2011 Dec 1;204(11):1796-805. doi: 10.1093/infdis/jir630. Epub 2011 Oct 4.

PMID:
21971287
12.

Identification, expression and serological evaluation of the recombinant ATP synthase beta subunit of Mycoplasma pneumoniae.

Nuyttens H, Cyncynatus C, Renaudin H, Pereyre S, Bébéar C.

BMC Microbiol. 2010 Aug 11;10:216. doi: 10.1186/1471-2180-10-216.

13.

Development of a real-time PCR targeting the yidC gene for the detection of Mycoplasma hominis and comparison with quantitative culture.

Férandon C, Peuchant O, Janis C, Benard A, Renaudin H, Pereyre S, Bébéar C.

Clin Microbiol Infect. 2011 Feb;17(2):155-9. doi: 10.1111/j.1469-0691.2010.03217.x.

14.

Evaluation of the combination of the NucliSENS easyMAG and the EasyQ applications for the detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in respiratory tract specimens.

Béssède E, Renaudin H, Clerc M, de Barbeyrac B, Bébéar C, Pereyre S.

Eur J Clin Microbiol Infect Dis. 2010 Feb;29(2):187-90. doi: 10.1007/s10096-009-0839-9. Epub 2009 Nov 26.

PMID:
19941020
15.

Life on arginine for Mycoplasma hominis: clues from its minimal genome and comparison with other human urogenital mycoplasmas.

Pereyre S, Sirand-Pugnet P, Beven L, Charron A, Renaudin H, Barré A, Avenaud P, Jacob D, Couloux A, Barbe V, de Daruvar A, Blanchard A, Bébéar C.

PLoS Genet. 2009 Oct;5(10):e1000677. doi: 10.1371/journal.pgen.1000677. Epub 2009 Oct 9.

16.

Detection and susceptibility testing of Mycoplasma amphoriforme isolates from patients with respiratory tract infections.

Pereyre S, Renaudin H, Touati A, Charron A, Peuchant O, Hassen AB, Bébéar C, Bébéar CM.

Clin Microbiol Infect. 2010 Jul;16(7):1007-9. doi: 10.1111/j.1469-0691.2009.02993.x. Epub 2009 Jul 15.

17.

Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.

Peuchant O, Ménard A, Renaudin H, Morozumi M, Ubukata K, Bébéar CM, Pereyre S.

J Antimicrob Chemother. 2009 Jul;64(1):52-8. doi: 10.1093/jac/dkp160. Epub 2009 May 9.

PMID:
19429926
18.

Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae.

Dégrange S, Cazanave C, Charron A, Renaudin H, Bébéar C, Bébéar CM.

J Clin Microbiol. 2009 Apr;47(4):914-23. doi: 10.1128/JCM.01935-08. Epub 2009 Feb 9.

19.

Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis.

Bébéar CM, de Barbeyrac B, Pereyre S, Renaudin H, Clerc M, Bébéar C.

Clin Microbiol Infect. 2008 Aug;14(8):801-5. doi: 10.1111/j.1469-0691.2008.02027.x.

20.

Reduced susceptibility to tetracyclines is associated in vitro with the presence of 16S rRNA mutations in Mycoplasma hominis and Mycoplasma pneumoniae.

Dégrange S, Renaudin H, Charron A, Pereyre S, Bébéar C, Bébéar CM.

J Antimicrob Chemother. 2008 Jun;61(6):1390-2. doi: 10.1093/jac/dkn118. Epub 2008 Mar 19. No abstract available.

PMID:
18356155
21.
22.
23.

Evaluation of moxalactam with the BD phoenix system for detection of methicillin resistance in coagulase-negative staphylococci.

Pupin H, Renaudin H, Join-Lambert O, Bébéar C, Mégraud F, Lehours P.

J Clin Microbiol. 2007 Jun;45(6):2005-8. Epub 2007 Apr 11.

24.

Characterisation of in vitro-selected mutants of Ureaplasma parvum resistant to macrolides and related antibiotics.

Pereyre S, Métifiot M, Cazanave C, Renaudin H, Charron A, Bébéar C, Bébéar CM.

Int J Antimicrob Agents. 2007 Feb;29(2):207-11. Epub 2006 Dec 28.

PMID:
17196370
25.

[Serologic diagnosis of chlamydial and Mycoplasma pneumoniae infections].

de Barbeyrac B, Obeniche F, Ratsima E, Labrouche S, Moraté C, Renaudin H, Pereyre S, Bébéar CM, Bébéar C.

Ann Biol Clin (Paris). 2006 Sep-Oct;64(5):409-19. Review. French.

26.

Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.

Pereyre S, Renaudin H, Charron A, Bébéar C, Bébéar CM.

J Antimicrob Chemother. 2006 Apr;57(4):753-6. Epub 2006 Feb 7.

PMID:
16464889
27.

In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively.

Gruson D, Pereyre S, Renaudin H, Charron A, Bébéar C, Bébéar CM.

Antimicrob Agents Chemother. 2005 Mar;49(3):1190-3.

28.

Increased expression of two multidrug transporter-like genes is associated with ethidium bromide and ciprofloxacin resistance in Mycoplasma hominis.

Raherison S, Gonzalez P, Renaudin H, Charron A, Bébéar C, Bébéar CM.

Antimicrob Agents Chemother. 2005 Jan;49(1):421-4.

29.

In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas.

Pereyre S, Renaudin H, Bébéar C, Bébéar CM.

Antimicrob Agents Chemother. 2004 Aug;48(8):3165-8.

30.

In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae.

Pereyre S, Guyot C, Renaudin H, Charron A, Bébéar C, Bébéar CM.

Antimicrob Agents Chemother. 2004 Feb;48(2):460-5.

31.

DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones.

Bébéar CM, Renaudin H, Charron A, Clerc M, Pereyre S, Bébéar C.

Antimicrob Agents Chemother. 2003 Oct;47(10):3323-5.

32.

Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis.

Pereyre S, Gonzalez P, De Barbeyrac B, Darnige A, Renaudin H, Charron A, Raherison S, Bébéar C, Bébéar CM.

Antimicrob Agents Chemother. 2002 Oct;46(10):3142-50.

33.

Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis.

Raherison S, Gonzalez P, Renaudin H, Charron A, Bébéar C, Bébéar CM.

Antimicrob Agents Chemother. 2002 Mar;46(3):672-9.

34.

In vitro activity of midecamycin diacetate against Mycoplasma pneumoniae and Chlamydia pneumoniae.

Pereyre S, de Barbeyrac B, Renaudin H, Poutiers F, Bébéar C, Bébéar CM.

J Antimicrob Chemother. 2001 Feb;47(2):240-1. No abstract available.

PMID:
11157917
35.
37.

Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas.

Bebear CM, Renaudin H, Bryskier A, Bebear C.

Antimicrob Agents Chemother. 2000 Jul;44(7):1980-2.

38.

Molecular typing of Mycoplasma pneumoniae strains by PCR-based methods and pulsed-field gel electrophoresis. Application to French and Danish isolates.

Cousin-Allery A, Charron A, de Barbeyrac B, Fremy G, Skov Jensen J, Renaudin H, Bebear C.

Epidemiol Infect. 2000 Feb;124(1):103-11.

39.

In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas.

Bébéar CM, Renaudin H, Schaeverbeke T, Leblanc F, Bébéar C.

J Antimicrob Chemother. 1999 May;43(5):711-4.

PMID:
10382895
40.

Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis.

Bebear CM, Renaudin J, Charron A, Renaudin H, de Barbeyrac B, Schaeverbeke T, Bebear C.

Antimicrob Agents Chemother. 1999 Apr;43(4):954-6.

41.

Alterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitro.

Bébéar CM, Renaudin H, Charron A, Bové JM, Bébéar C, Renaudin J.

Antimicrob Agents Chemother. 1998 Sep;42(9):2304-11.

42.

In vitro activity of BAY 12-8039, a new fluoroquinolone against mycoplasmas.

Bébéar CM, Renaudin H, Boudjadja A, Bébéar C.

Antimicrob Agents Chemother. 1998 Mar;42(3):703-4.

43.

New developments in diagnostic and treatment of mycoplasma infections in humans.

Bébéar C, de Barbeyrac B, Bébéar CM, Renaudin H, Allery A.

Wien Klin Wochenschr. 1997 Aug 8;109(14-15):594-9. Review.

PMID:
9286066
44.

In-vitro activity of ketolides against mycoplasmas.

Bébéar CM, Renaudin H, Aydin MD, Chantot JF, Bébéar C.

J Antimicrob Chemother. 1997 May;39(5):669-70. No abstract available.

PMID:
9184373
45.

Systematic detection of mycoplasmas by culture and polymerase chain reaction (PCR) procedures in 209 synovial fluid samples.

Schaeverbeke T, Renaudin H, Clerc M, Lequen L, Vernhes JP, De Barbeyrac B, Bannwarth B, Bébéar C, Dehais J.

Br J Rheumatol. 1997 Mar;36(3):310-4.

PMID:
9133961
46.
47.

Arbitrarily-primed PCR confirms the differentiation of strains of Ureaplasma urealyticum into two biovars.

Grattard F, Pozzetto B, de Barbeyrac B, Renaudin H, Clerc M, Gaudin OG, Bébéar C.

Mol Cell Probes. 1995 Dec;9(6):383-9.

PMID:
8808308
48.

In vitro susceptibility of mycoplasmas to a new quinolone, BAY Y 3118.

Renaudin H, Bébéar C.

Drugs. 1995;49 Suppl 2:243-5. No abstract available.

PMID:
8549318
49.

Detection of Mycoplasma pneumoniae and Mycoplasma genitalium in clinical samples by polymerase chain reaction.

de Barbeyrac B, Bernet-Poggi C, Fébrer F, Renaudin H, Dupon M, Bébéar C.

Clin Infect Dis. 1993 Aug;17 Suppl 1:S83-9.

PMID:
8399944
50.

Potential improvements in therapeutic options for mycoplasmal respiratory infections.

Bébéar C, Dupon M, Renaudin H, de Barbeyrac B.

Clin Infect Dis. 1993 Aug;17 Suppl 1:S202-7. Review.

PMID:
8399917

Supplemental Content

Loading ...
Support Center